Solve.Care partners with AliveCor

Collaboration provides KardiaMobile users quick access to doctors worldwide for consultations about their ECG readings

Solve.Care has partnered with AliveCor to enable users of AliveCor’s KardiaMobile devices and services to easily book teleconsultations with physicians on the Global Telehealth Exchange (GTHE) network. Through this partnership, physicians on the network will be able to seamlessly access users’ KardiaMobile electrocardiogram (ECG) readings, upon their consent. The KardiaMobile 6L device is the first and only six-lead personal ECG cleared by the US Food and Drug Administration (FDA). It detects more arrhythmias than any other personal ECG device. GTHE is an open global cross-border telehealth network that enables doctors and patients to connect worldwide. 


The partnership will see KardiaMobile devices integrated with Solve.Care’s blockchain platform enables its users to connect with a physician on GTHE directly through the Kardia app to share their ECG readings during their teleconsultations. As physicians have access to previous ECG readings stored by KardiaMobile, this will provide physicians with a more complete understanding of the patient’s symptoms to facilitate more effective ongoing care. As GTHE is built using blockchain technology, all data is fully secured and remains in control of the patient. 

Conversely, GTHE patients can purchase KardiaMobile devices directly in their Care.Wallet using SOLVE tokens, Solve.Care’s native digital currency is used to pay for healthcare services. Care.Wallet is Solve.Care’s healthcare management app (available in the Apple App Store and Google Play Store) is used to access various healthcare networks, including GTHE. 

The agreement facilitates greater access to care, widening their choice of instantly booking a tele-consult with any specialised physician throughout the world through their mobile devices.

Support us in our endeavor to bring you Advertisement free content.
Choose your options to donate or subscribe.


Related Articles

Leave a Reply

Back to top button